Sei sulla pagina 1di 3

Kabra Dru$s Limited

lK.

Regd. Office & Works :


Ptot No. 26, Sector 'A' Sanwer Road,
lndustrial Estate, lNDORE 452 015

a :

0731-297 1305, 6501305

E-mail : kabradrugs@rediffmail.com
: www.kabradrugsltd.com

Website

CIN : LO2423MPl 989PLC005438

Date: 13th August, 2016


To,

The Corporate Relationship Department,

Limited,
Phiroze Jeeieebhoy Towers, Dalal Street,
Mumbai - 400 001 (MH)
BSE

Reft Scrip

Code 524322

Sub: Outcome of Board Meeting 2/2OL6 -Unaudited Standalone Financial Results for
the quarter ended 30th June, with Limited Review Report.

Dear Sir/Madam,

compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure


Requirements) Regulations, 2075, we are pleased to enclose the Unaudited Standalone
Financial Results for the quarter ended 30s June, 2016 along with Limited Review Report
which have been duly approved by the Board of Directors in its meeting held on 13d" August,
2016. The Board Meeting commenced at 01.00 P.M. and concluded at 04.00 P.M.

In

Kindly take the same on your records

Thanking you,
Yours faithfully,
FOR, KABRA DRUGS LI

t@

ANCHAL KABRA

COMPANY SECRETAR

Encl: As above

o RU

*
o

IK

Kabra Drugs Limited


Regd. Office & Works :
Plot No. 26, Sector'A' Sanwer Road,
lndustrial Estate, INDORE-452 015

A |

0731-297 1305, 6501305


E-mail : kabradrugs@rediffmail.com
Website : www.kabradrugsltd.com

CIN : LO2423MP1989PLC005438

Part I

Statement of Standalone Unaudited Results forthe 0uarter Ended 30.06.2016


Rs ln lacs
Preceding 3
Coffespond Year to date
3 figures for
months ended

3 Months

ing

ended

CuffentPeriod

months
S. No.

ended

PARTICULARS
Notes Below

lJnaudited
30.06.2016

Income from operations


(a)Net sales /lncome from operatron
(b)0ther 0perating income
Total income frofl Operations (net)

Audited
31.03.2016

301.18
0.98

245.06
0.10

965.45

t77.ll

302.L6

245.76

967.OA

tla.z2

240.55
0.00

793.25
0.00

727.43
0.00

0.00

163

1.10
14.21

66.16

33.39

0.99
27.86
5.76
37.86

25.47

L42.57

t7 4.00

307.02

239.57

962.17

3.11

-4.46

0.00

0.00

0.00

0.00

3.11

-4.46

5.65

4.91

0.00

0.00

0.00

0.00

(5+61

3.11

-4.46

5.65

4.9r

ExceDtlonal items

0.00

0.00

0.00

0.00

Pront / (Loss)from OrdirEry Activities


before tax f7+B)

3.11

-4.46

5.65

4,9L

0.00

0.00

0.00

2.11

3.11

-4.86

5.65

2.7

0.00

0.00

0.00

0.00

3.11
0.00
0.00

-4.86
0.00
0.00

5.65
0.00
0.00

2.7

2.74
434.46

Proiii-Loss)

(7-Zl
4 0ther Income
5 Profr 7Oo-ss If romOrdinaryactivities
before finance costs and Exceptional ltems
(3+41

6 Finance Costs
7 Profit / (Loss) from ordinary activities after
linance costs but before exceptional ltems
B

Audited Unaudited
31.03.2016 30.06.2015

1.51

175.60

2 Expenses
(a) Cost ofmaterials consumed
(b) Purchase of Stock -in- Trade
(c) Change in inventories offinished goods,
work -in-progress and stock'in_tIade
(d) Employee benefits expense
(e) Depreciation and amortisatron expense
(f ) otler Expenses
Total exDenses
from operations before other
3
Income, Finance costs and Exceptional ltems

in

10 Tax expences
11 Net Profit/[Loss) from

rd

inarv Activities aft

tz

Extraordinarv ltemsf net oftax exDensel


13 Net Profit /tloss)for the Deriod[11-121
14 Share of Profit/ 0oss) ofassociates
15 Minority Interest
16 Net protit / (Loss) after taxes, minority
interest and share of prolit/ 0oss) of

associates
Paid up equity share capital
fFace value ofRs,10 each]
1B Resen es excluding Revaluation Reserves as
per Balance sheet ofprevious accounting

t7

1.97

14.66
5.7 6

24.31

4.91

3.11

-4.46

5.65

438.86

438.86

438,86

yeaf

]I

0.00
0.00

175.63

Drugs Ltd.,
Director.

IK

Kabra Drugs Limited


Regd. Office & Works :
Ptot No. 26, Sector 'A' Sanwer Road,
lndustrial Estate, INDORE-452 015

A : 0731-2971305, 6501305
: kabradrugs@rediffmail.com
Website : www.kabradrugsltd.com
E-mail

CIN : LO2423MP1989PLC005438

t9

i. Earning per share

(before Extraordinary

(ofRs.10 eacb) (not annualised)


0.07

-0.11

0.13

0.05

o.o7

-0.11

0.13

0.06

fal Basic

0.07

-0.11

0.13

0.06

(b) Diluted

o.o7

-0.11

0.13

0.06

[a) Basic
(b) Diluted
ii. Earnine nershare {after extraordinarv
(ofRs.10 each) (not annualised)

1 The above results duly reviewed by Audit Committee, have been approved by the Board of
Directors in its meetingheld on 13th August,2016.
2 Previous year fiBures have been regrouped/rearranged wherever necessary
3 Statutory auditors ofthe companyhave carried out a limited reviewofabove result

Forand on
Plae : Indore

behalfofthe
rd

Date :13.08.2016

Ltd

RMAN AND
MANAGING
DIRECTOR

Din:0O76O020

Director.

Potrebbero piacerti anche